Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Philip A. Rowlings"'
Publikováno v:
Journal of NeuroVirology. 26:961-963
Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease affecting the central nervous system as a result of reactivation of the John Cunningham (JC) polyomavirus and occurs almost exclusively in immunosuppressed individuals. The d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2d6896904078d53ec596511d41ff8c1
https://doi.org/10.1007/s13365-020-00899-0
https://doi.org/10.1007/s13365-020-00899-0
Publikováno v:
Cancer Genetics. :1-9
Plasma cell disorders (PCD) range from benign to highly malignant disease. The ability to detect risk-stratifying aberrations based on cytogenetic and molecular genetic assays plays an increasing role in therapeutic decision making. In this study, 58
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7a68573627b3fb6eb94d2e240a06364
https://doi.org/10.1016/j.cancergen.2017.08.004
https://doi.org/10.1016/j.cancergen.2017.08.004
Autor:
Juliana Di Iulio, Paul Cannell, Andrew W. Roberts, Anthony K. Mills, Warwick J. Benson, Andrew H. Wei, James D'Rozario, John Moore, Mark P. Hertzberg, Emma Link, Ray M. Lowenthal, Michael F. Leahy, Luke Coyle, Campbell Tiley, John Taper, Phillip Campbell, Lynda J. Campbell, Ian D. Lewis, Ilona Cunningham, A Enno, Philip A. Rowlings, Peter G Bardy, Jeff Szer, Paula Marlton, Andrew Grigg, Anthony P. Schwarer, Uwe Hahn, Kenneth F. Bradstock, Kimberly Cartwright, Devinder Gill, John F. Seymour, Gavin Cull, Sandra Deveridge
Publikováno v:
Journal of Clinical Oncology. 35:1678-1685
Purpose Higher doses of the anthracycline daunorubicin during induction therapy for acute myeloid leukemia (AML) have been shown to improve remission rates and survival. We hypothesized that improvements in outcomes in adult AML may be further achiev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::011013f2d68ccee47a132bdc60459497
https://doi.org/10.1200/jco.2016.70.6374
https://doi.org/10.1200/jco.2016.70.6374
Autor:
S. Vincent Rajkumar, Dawn Odom, Vladimir Maisnar, Ivan Spicka, Philip A. Rowlings, Kaveri Suryanarayan, Hartmut Goldschmidt, Fredrik Schjesvold, Dorothy Romanus, Lauren E. Cain, Niels Abildgaard, Meletios A. Dimopoulos, Ari Gnanasakthy
Publikováno v:
Dimopoulos1, M, Goldschmidt, H, Maisnar, V, Spicka, I, Abildgaard, N, Rowlings, P, Rajkumar, S V, Cain, L, Romanus, D, Suryanaryan, K, Odom, D, Gnanasakthy, A & Schjesvold, F H 2019, ' Health-related quality of life is maintained with ixazomib maintenance in posttransplant newly diagnosed multiple myeloma: the TOURMALINE-MM3 trial ', Clinical Lymphoma, Myeloma & Leukemia, vol. 19, no. 10 Suppl., SP-151, pp. 290-291 . https://doi.org/10.1016/j.clml.2019.09.477
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba47bb2ac9ecab05555140944970398e
https://portal.findresearcher.sdu.dk/da/publications/84bc3cf5-daf7-48d6-a42f-061b36ca225b
https://portal.findresearcher.sdu.dk/da/publications/84bc3cf5-daf7-48d6-a42f-061b36ca225b
Autor:
Fredrik Schjesvold, Meletios A. Dimopoulos, Philip A. Rowlings, Ivan Spicka, Vladimir Maisnar, Niels Abildgaard, Hartmut Goldschmidt, Dorothy Romanus, Ari Gnanasakthy, Dawn Odom, Kaveri Suryanarayan, Vincent Rajkumar, Lauren E. Cain
Publikováno v:
Schjesvold, F, Goldschmidt, H, Maisnar, V, Spicka, I, Abildgaard, N, Rowlings, P, Cain, L, Romanus, D, Suryanarayan, K, Rajkumar, V, Odom, D, Gnanasakthy, A & Dimopoulos, M 2020, ' Quality of life is maintained with ixazomib maintenance in post-transplant newly diagnosed multiple myeloma : the TOURMALINE-MM3 trial ', European journal of haematology, vol. 104, no. 5, pp. 443-458 . https://doi.org/10.1111/ejh.13379
Objectives: Health-related quality of life (HRQoL) is particularly important during maintenance therapy (MT) in newly diagnosed multiple myeloma post-transplant, when disease symptoms are limited. Methods: We assessed HRQoL in patients randomised to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f5aa1659c9efb350e418693ace32b45
https://pubmed.ncbi.nlm.nih.gov/31880006
https://pubmed.ncbi.nlm.nih.gov/31880006
Publikováno v:
Critical reviews in oncology/hematology. 142
Single nucleotide polymorphism (SNP) microarrays are commonly used for the clinical investigation of constitutional genomic disorders; however, their adoption for investigating somatic changes is being recognised. With increasing importance being pla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31439cbe42c516c7617b348ff3d8cce4
https://pubmed.ncbi.nlm.nih.gov/31377433
https://pubmed.ncbi.nlm.nih.gov/31377433
Autor:
Baldeep Wirk, Marcelo C. Pasquini, Yoshiko Atsuta, Biju George, Tatsuo Ichinohe, Theresa Hahn, David I. Marks, Yachiyo Kuwatsuka, Wael Saber, Mahmoud Aljurf, Jean-Yves Cahn, Kwang Woo Ahn, Aloysius Ho, Fumihiko Kimura, Rajat Kumar, Zhen-Huan Hu, Vikas Gupta, Yoshihiro Inamoto, John P. Klein, Philip A. Rowlings, Jignesh Dalal, Koichi Miyamura, Koji Kato, Anders Fasth, Laurence Dedeken, Carmem Bonfim, Ayami Yoshimi, Kirk R. Schultz, Nandita Khera, Jeff Szer, William A. Wood, Jong Wook Lee, Matthew D. Seftel
Publikováno v:
Biology of blood and marrow transplantation, 22 (5
Bone marrow (BM) is the preferred graft source for hematopoietic stem cell transplantation (HSCT) in severe aplastic anemia (SAA) compared with mobilized peripheral blood stem cells (PBSCs). We hypothesized that this recommendation may not apply to t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce8dfe7a42e36f0c9b005ba9429092c1
https://doi.org/10.1016/j.bbmt.2016.01.012
https://doi.org/10.1016/j.bbmt.2016.01.012
Autor:
Cindy Lee, P. Joy Ho, Bradley Auguston, Kah-Lok Chan, Simon J. Harrison, Anne-Marie Watson, Pauline Warburton, Hang Quach, Kirk Morris, Sundra Ramanathan, Nicholas Weber, Philip A. Rowlings, Fiona Kwok, Peter Mollee, Anthony J. Dodds, Campbell Tiley, Richard Stark, John Taper, Raj Ramakrishna, Ashleigh P Scott, Kerry Taylor
Publikováno v:
Leukemia & Lymphoma. 59:1514-1516
Pomalidomide and low-dose dexamethasone prolongs progression-free and overall survival in patients with relapsed/refractory multiple myeloma following lenalidomide and bortezomib. As with other IMI...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f2699ca5bad7b40ccf714dab8a41a496
https://doi.org/10.1080/10428194.2017.1387911
https://doi.org/10.1080/10428194.2017.1387911
Autor:
M.A. Dimopoulos, K. Suryanarayan, S V Rajkumar, Ivan Spicka, Dorothy Romanus, N. Abildgaard, Lauren E. Cain, D. Odom, H. Goldschmidt, V. Maisnar, Fredrik Schjesvold, Philip A. Rowlings, A. Gnanasakthy
Publikováno v:
HemaSphere. 3:266-267
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93f67c1dcfe13a7069fc06f6843baa29
https://doi.org/10.1097/01.hs9.0000560788.86257.a3
https://doi.org/10.1097/01.hs9.0000560788.86257.a3
Autor:
Neil P. Shah, Philip A. Rowlings, Jorge E. Cortes, François Xavier Mahon, Kyna Gooden, Philipp le Coutre, Glenn S. Kroog, Jiří Mayer, Giuseppe Saglio, Milayna Subar
Publikováno v:
Annals of hematology, vol 96, iss 8
Annals of Hematology
Annals of Hematology
With high survival rates for chronic myeloid leukemia (CML) patients treated with BCR-ABL1 tyrosine kinase inhibitors (TKIs), emerging consequences, such as arterial ischemic events, require consideration when evaluating treatment options. Cardiovasc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65800c0b628baa5f98ecc1e11eafcdee
https://escholarship.org/uc/item/1361k75x
https://escholarship.org/uc/item/1361k75x